tiprankstipranks
Advertisement
Advertisement

NGNE Stock Latest News

Analyst Reiterates Buy on Neurogene, Maintains $70 Price Target on Promising NGN-401 Profile and Solid Cash Runway
RatingsAnalyst Reiterates Buy on Neurogene, Maintains $70 Price Target on Promising NGN-401 Profile and Solid Cash Runway
2d ago
NGNE
Neurogene Maintains Buy Rating as Embolden Trial Progresses and Cash Runway Supports Unchanged $180 Price Target
PremiumRatings
Neurogene Maintains Buy Rating as Embolden Trial Progresses and Cash Runway Supports Unchanged $180 Price Target
7d ago
NGNE
Neurogene reports Q1 EPS ($1.39), consensus ($1.27)
PremiumThe Fly
Neurogene reports Q1 EPS ($1.39), consensus ($1.27)
7d ago
NGNE
Is NGNE a Buy, Before Earnings?
PremiumPre-Earnings
Is NGNE a Buy, Before Earnings?
14d ago
NGNE
Neurogene to present on ICV delivery in CNS-targeted gene therapy
PremiumThe Fly
Neurogene to present on ICV delivery in CNS-targeted gene therapy
22d ago
NGNE
Neurogene initiated with a Buy at Guggenheim
PremiumThe FlyNeurogene initiated with a Buy at Guggenheim
22d ago
NGNE
Neurogene Expands Leadership Team to Drive NGN-401 Commercialization
Premium
Company Announcements
Neurogene Expands Leadership Team to Drive NGN-401 Commercialization
30d ago
8K
NGNE
Neurogene appoints Christy Shafer as CCO
Premium
The Fly
Neurogene appoints Christy Shafer as CCO
30d ago
NGNE
Compelling Risk‑Reward in Neurogene’s NGN-401: Differentiated Gene Therapy Approach in Rett Syndrome Supports Buy Rating
PremiumRatings
Compelling Risk‑Reward in Neurogene’s NGN-401: Differentiated Gene Therapy Approach in Rett Syndrome Supports Buy Rating
1M ago
NGNE
3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026
PremiumMarket News
3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026
1M ago
UPB
AIOT
Neurogene price target lowered to $180 from $200 at Canaccord
PremiumThe Fly
Neurogene price target lowered to $180 from $200 at Canaccord
1M ago
NGNE
Buy Rating Backed by Strong NGN-401 Clinical Progress, De-Risking Efficacy Data, and Solid Cash Runway in Rett Syndrome
PremiumRatings
Buy Rating Backed by Strong NGN-401 Clinical Progress, De-Risking Efficacy Data, and Solid Cash Runway in Rett Syndrome
2M ago
NGNE
Buy Rating Underpinned by De-Risked NGN‑401 Development, Aligned Manufacturing Strategy, and Cash Runway Through Key 2027–28 Catalysts
PremiumRatingsBuy Rating Underpinned by De-Risked NGN‑401 Development, Aligned Manufacturing Strategy, and Cash Runway Through Key 2027–28 Catalysts
2M ago
NGNE
Neurogene Advances Rett Gene Therapy Toward BLA With Strong Cash Runway
Premium
Company Announcements
Neurogene Advances Rett Gene Therapy Toward BLA With Strong Cash Runway
2M ago
NGNE
1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts
Premium
Market News
1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts
2M ago
NGNE
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
PremiumThe Fly
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
2M ago
EL
RL
Neurogene reports FY25 EPS ($4.24) vs ($4.28) last year
PremiumThe Fly
Neurogene reports FY25 EPS ($4.24) vs ($4.28) last year
2M ago
NGNE
NGNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
NGNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
NGNE
Block upgraded, Duolingo downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Block upgraded, Duolingo downgraded: Wall Street’s top analyst calls
3M ago
HON
LUV
Canaccord starts Neurogene with Buy rating, $200 price target
PremiumThe FlyCanaccord starts Neurogene with Buy rating, $200 price target
3M ago
NGNE
Neurogene initiated with a Buy at Canaccord
Premium
The Fly
Neurogene initiated with a Buy at Canaccord
3M ago
NGNE
Neurogene jumps 36% to $26.71 after Canaccord puts $200 target on shares
Premium
The Fly
Neurogene jumps 36% to $26.71 after Canaccord puts $200 target on shares
3M ago
NGNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >